Michael McCully

Co-Founder, President & CEO at Gate Neurosciences, Inc.

Michael McCully is the President & CEO of Gate Neurosciences, a company dedicated to addressing the challenges in developing new treatments for CNS and neuropsychiatric conditions.

He holds a Master's degree in Biotechnology & Business from Northwestern University and a Bachelor's degree in Plant Molecular Biology from Purdue University.

Michael has a rich professional background, having served in various leadership roles in esteemed organizations such as Anagin Inc, Terranova Bioventures, Locust Walk, Charleston Laboratories, Coherus Biosciences, Elan Pharmaceuticals, RedLeaf Bioventures LLC, Deloitte, and Burrill & Company.

His expertise spans across business development, financial strategy, bioventures, and advisory practices within the life sciences industry.

With a strong academic foundation and extensive experience in the field, Michael McCully continues to drive innovation and progress in the development of treatments for CNS and neuropsychiatry disorders.